pharma&
Marius Roeske currently serves as Senior Director of Business Development at pharma& since May 2023. Prior to this role, Marius held the position of Vice President in Private Debt at BlackRock from September 2019 to May 2023. Marius gained valuable experience at UniCredit, where responsibilities included Acquisition and Leveraged Finance and participation in Financial Sponsor Solutions from March 2015 to August 2019. Additionally, Marius worked in the Integrated Degree Program at HypoVereinsbank - UniCredit - Deutschland, focusing on private, corporate, and investment banking, while specializing in Corporate Finance Advisory and Equity Capital Markets from August 2011 to March 2015. An Academic Research Assistant role was held at HM - Faculty of Business Administration in 2012-2013, providing research support. Marius Roeske holds a Bachelor of Business Administration from Munich University of Applied Sciences and a Certified Financial Modeler credential from the Deutsches Institut für Corporate Finance.
This person is not in any offices
pharma&
1 followers
pharmaand GmbH (pharma&), a privately owned global company, aspires to breathe new life into proven medicines through our agile and fully integrated business model, guaranteeing the enduring availability, dependability, and quality of essential drugs worldwide that patients and healthcare providers rely on. Whether a former blockbuster or niche medicine, we acquire the worldwide rights to specialty treatments to secure long-term access to established and essential medicines across various specialized therapy areas, doing whatever it takes to maintain and develop the value of these medicines for all who depend on them. We’ve acquired and integrated 11 medicines over the past five years, expanding our portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments. Our unique, fully integrated model across pharma&’s subsidiaries, joint ventures, and partners enables us to provide our portfolio of medicines to eligible healthcare providers and patients worldwide, spanning the continuum of manufacturing, distribution, administration/access, and patient support.